奥司他韦
註釋

1 2 3 4 5  Davies, BE.  (PDF). The Journal of antimicrobial chemotherapy. April 2010,. 65 Suppl 2: ii5–ii10  [2015-03-30]. PMC 2835511 . PMID 20215135. doi:10.1093/jac/dkq015. （原始内容存档 (PDF)于2017-09-08）.
1 2 3 4 5 6  . The American Society of Health-System Pharmacists.   [2017-01-08]. （原始内容存档于2016-05-13）.
1 2 3  . U.S. Centers for Disease Control and Prevention (CDC). 2014-04-10  [2017-01-16]. （原始内容存档于2017-01-18）.
↑  European Centre for Disease Prevention and Control. . 2014-06-02  [2020-07-20]. （原始内容存档于2014-11-02）.
↑  . National Institute for Health and Care Excellence (NICE). 2009-02-25  [2017-01-16]. （原始内容存档于2017-01-18）.
↑  .   [2014-04-24]. （原始内容存档于2014-04-24）.
↑  Brownlee S. . The Atlantic. 2013-02-19  [2014-12-07]. （原始内容存档于2014-12-29）.
1 2  Butler D. . Nature. April 2014, 508 (7497): 439–40. Bibcode:2014Natur.508..439B. PMID 24759392. doi:10.1038/508439a .
1 2  Michiels B, Van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S. Jefferson T , 编. . PLOS ONE. 2013, 8 (4): e60348. Bibcode:2013PLoSO...860348M. PMC 3614893 . PMID 23565231. doi:10.1371/journal.pone.0060348 .
1 2  Ebell MH, Call M, Shinholser J. . Family Practice. April 2013, 30 (2): 125–33. PMID 22997224. doi:10.1093/fampra/cms059 .
↑  Okoli GN, Otete HE, Beck CR, Nguyen-Van-Tam JS. . PLOS ONE. 2014-12-09, 9 (12): e113633. Bibcode:2014PLoSO...9k3633O. PMC 4260958 . PMID 25490762. doi:10.1371/journal.pone.0113633.
↑  Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Harnden A , 编. . The Cochrane Database of Systematic Reviews. April 2012, 4 (4): CD002744. PMC 6599832 . PMID 22513907. doi:10.1002/14651858.CD002744.pub4.
↑  Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. . BMJ. April 2014, 348: g2545. PMC 3981975 . PMID 24811411. doi:10.1136/bmj.g2545.
↑  . Drugs.com.   [2017-01-16]. （原始内容存档于2017-09-09）.
↑  Agrawal R, Rewatkar PV, Kokil GR, Verma A, Kalra A. . Medicinal Chemistry. July 2010, 6 (4): 247–51. PMID 20843284. doi:10.2174/1573406411006040247.
↑  . World Health Organization.
↑  Ebell, Mark H. . BMJ. 2017-07-12: j3266. doi:10.1136/bmj.j3266.
↑  . U.S. Food and Drug Administration (FDA). 2016-08-04  [2016-08-06]. （原始内容存档于2016-08-08）.
↑  . U.S. Food and Drug Administration (FDA).   [2020-01-09]. （原始内容存档于2017-11-30）.
↑  . ClinCalc.   [2018-12-22]. （原始内容存档于2020-03-18）.
↑  . ClinCalc.   [2020-04-11]. （原始内容存档于2021-03-08）.
↑  .   [2005-12-23]. （原始内容存档于2005-12-24）.
↑  http://news8.thdo.bbc.co.uk/chinese/simp/hi/newsid_4550000/newsid_4554100/4554142.stm%5B%5D
↑  Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc.; (Article); 1997; 119(4); 681-690.  
doi:10.1021/ja963036t
↑  Practical Total Synthesis of the Anti-Influenza Drug GS-4104 John C. Rohloff, Kenneth M. Kent, Michael J. Postich, Mark W. Becker, Harlan H. Chapman, Daphne E. Kelly, Willard Lew, Michael S. Louie, Lawrence R. McGee, Ernest J. Prisbe, Lisa M. Schultze, Richard H. Yu, and Lijun Zhang J. Org. Chem.; 1998; 63(13) pp 4545 - 4550; (Note) doi:10.1021/jo980330q.
↑  Abrecht, S.; Harrington, P.; Iding, H.; Karpf, M.; Trussardi, R.; Wirz, B.; Zutter, U. Chimia 2004, 58, 621.
↑  . 南方都市报. 2003年2月15日  [2013-12-06]. （原始内容存档于2020-12-06）.